HIV-1 inhibitor-35
Product Specifications
UNSPSC Description
HIV-1 inhibitor-35 (compound 74) is a potent HIV-1 inhibitor with EC50s of 80 nM and 70 nM for LTR and CMV in HEK293 cells, respectively. HIV-1 inhibitor-35 has inhibitory activity against liver cancer cell HepG2 with a CC50 of 40 nM. HIV-1 inhibitor-35 can be used as HIV-1 latency reversing agent[1].
Target Antigen
HIV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hiv-1-inhibitor-35.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CCN(CC1)C2=CN=C(C(Cl)=C2)Cl)NC3=NC=C(S3)Cl
Molecular Weight
392.69
References & Citations
[1]Nguyen W, et al. Optimization of 5-substituted thiazolyl ureas and 6-substituted imidazopyridines as potential HIV-1 latency reversing agents. Eur J Med Chem. 2020;195:112254.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-147552/HIV-1-inhibitor-35-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-147552/
Clinical Information
No Development Reported
CAS Number
2416971-32-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP3-24291R 0.1 mL
Rabbit Monoclonal Cytokeratin 14 Antibody (KRT14/8260R) [DyLight 550]
Ask
View Details 